2023 Annual Meeting | C185 - Spanish Language: Neuroimmunology

Date Wednesday 04/26/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Helena Arino, MD, PhD

Topic(s) Autoimmune Neurology

Learning Objectives Participants should become familiar with the current therapeutic challenges in antibody-associated neurologic disorders and with the diverse ongoing clinical trials that will change the landscape of therapeutic options. In particular, participants should be able to recognize new therapeutic targets in autoimmune encephalitis and myasthenia gravis, and develop strategies to manage immune-related adverse events of immune checkpoint inhibitors in oncologic patients.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Quality Improvement

Program Level Intermediate

Program Tracks Spanish Language

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 03:35 PM EST	Introduction	Introducción y Bienvenida Helena Arino, MD, PhD
03:35 PM - 04:05 PM EST	Speaker	Tratamiento de la Encefalitis Autoinmune. Presente y Futuro Helena Arino, MD, PhD
04:05 PM - 04:40 PM EST	Speaker	Tratamiento Farmacológico en Miastenia Gravis. ¿Qué Debemos Conocer de los Tratamientos que Llegan? Eugenia Martinez-Hernandez, MD
04:40 PM - 05:15 PM EST	Speaker	Complicaciones Neurológicas de los Inhibidores del Punto de Control Inmunitario. Claves Diagnósticas y Manejo Roser Velasco Fargas
05:15 PM - 05:30 PM EST	Discussion	Preguntas y Discusión Helena Arino, MD, PhD

Faculty Disclosures
Helena Arino, MD, PhD	Dr. Arino has nothing to disclose.
Roser Velasco Fargas	Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Roser Velasco Fargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving as a Consultant for Seagen. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Roser Velasco Fargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. The institution of Roser Velasco Fargas has received research support from ISCIII.
Eugenia Martinez-Hernandez, MD	Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. The institution of Dr. Martinez-Hernandez has received research support from Fundacio La Caixa. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria and attending meetings with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a speaker honoraria with Terumo. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.

��ɫ��

��ɫ��